Gornitzky represented the underwriters, led by Barclays Capital Inc. and UBS Securities LLC, in the USD 70 million initial public offering of InMode Ltd. on the NASDAQ Global Select Market. InMode develops, manufactures, and markets devices harnessing novel radio-frequency (RF) technology. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
Barclays Capital Inc. and UBS Securities LLC acted as the representatives of the underwriters and joint book-running managers for the offering. Canaccord Genuity LLC acted as lead manager for the offering. Robert W. Baird & Co. Incorporated acted as co-manager for the offering.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Neta Peled (Associate), Yoav Meer (Associate) and Sharon Reingwirtz (Associate).